Charles Schwab Investment Management »

Apellis Pharmaceuticals shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $54M 904k 59.86
2023-09-30 $34M 879k 38.04
2023-06-30 $76M 829k 91.10
2023-03-31 $65M 984k 65.96
2022-12-31 $51M 983k 51.71
2022-09-30 $65M 949k 68.30
2022-06-30 $31M 678k 45.22
2022-03-31 $33M 655k 50.81
2021-12-31 $28M 592k 47.28
2021-09-30 $17M 519k 32.96
2021-06-30 $27M 419k 63.20
2021-03-31 $17M 404k 42.91
2020-12-31 $22M 376k 57.20
2020-09-30 $11M 369k 30.17
2020-06-30 $12M 362k 32.66
2020-03-31 $8.9M 331k 26.79
2019-12-31 $8.2M 269k 30.62
2019-09-30 $6.3M 261k 24.09
2019-06-30 $6.2M 246k 25.34
2019-03-31 $4.1M 211k 19.50
2018-12-31 $2.5M 192k 13.19
2018-09-30 $3.4M 193k 17.78
2018-06-30 $3.8M 172k 22.00
2018-03-31 $944k 43k 22.11
2017-12-31 $863k 40k 21.72